Registry for assessing treatments of benign prostatic hyperplasia
Database for the Assessment of Efficacy and Safety of BPH Treatment
This study is collecting information to see how well different treatments for enlarged prostate symptoms work, comparing new options with traditional ones for men aged 18 and older.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Cantonal Hospital of St. Gallen Academic / other |
| Locations | 1 site (Sankt Gallen, Canton of St. Gallen) |
| Trial ID | NCT03521648 on ClinicalTrials.gov |
What this trial studies
This registry collects data on the efficacy and safety of various treatments for benign prostatic enlargement (BPE) and lower urinary tract symptoms (BPH-LUTS). It includes clinical, patient-reported, and imaging data from patients treated at the urological department of St. Gallen Cantonal Hospital. The study aims to compare novel treatment options, such as prostatic artery embolization, with established interventions like TURP and laser therapies. Participation requires informed consent from patients aged 18 and older.
Who should consider this trial
Good fit: Ideal candidates are adult patients aged 18 and older who are being treated for BPH or LUTS at the participating institution.
Not a fit: Patients with cognitive impairments that prevent them from providing informed consent or adequately assessing data will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the most effective treatments for benign prostatic hyperplasia, improving patient outcomes.
How similar studies have performed: Other studies have successfully assessed treatment efficacy for BPH, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG * Patient age ≥ 18 years * Informed consent provided Exclusion Criteria: -Cognitive impairment not allowing Informed Consent or adequate data assessment.
Where this trial is running
Sankt Gallen, Canton of St. Gallen
- St. Gallen Cantonal Hospital — Sankt Gallen, Canton of St. Gallen, Switzerland (Recruiting)
Study contacts
- Study coordinator: Dominik Abt, MD
- Email: dominik.abt@kssg.ch
- Phone: +41 71 494 14 16
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.